News

GRID3 Webinars: Ready for the shift

April 17, 2020

The rapid spread of COVID-19 across borders has caused companies and organisations worldwide to fundamentally rethink and restructure the way they work. Telecommuting replaced office life, and e-learning substituted in-person workshops on a global scale. While GRID3 operations have not been untouched by the pandemic, the partnership’s reliance on innovative learning solutions since its inception has allowed for a fast adaptation to the new circumstances.

GRID3 has recently launched a webinar series in which GRID3 experts break down technical details about our work in a user-friendly and easily understandable manner. The series will include webinars about settlements, boundaries, population modeling, census, and other areas of GRID3 expertise.

To kick off the series, GRID3 experts introduce settlement work, detailing how we create and categorise settlement layers with potential health applications. See the video below.

All GRID3 webinars will be available through our website and our Youtube channel. Don’t hesitate to send us feedback or questions!

 

 

Featured photo credit: FredR

More news

May 23, 2023
Nigeria uses GRID3 data in its push to vaccinate its population against COVID-19

In Nigeria, the need to boost COVID-19 vaccination rates in areas with low vaccine uptake was a key priority for the country’s government. Learn how GRID3 geospatial data supported these COVID-19 vaccination efforts.

April 5, 2023
Innovative online course attracts learners from across the globe

Between November 2022 and January 2023, GRID3’s self-paced online course provided learners from across the world the opportunity to learn about geographic information system (GIS) applications.

February 23, 2023
Sierra Leone tackles HPV in its latest nationwide vaccination campaign

Sierra Leone’s Ministry of Health and Sanitation and its Expanded Programme on Immunization (EPI) embarked on a campaign with Clinton Health Access Initiative, Gavi, GRID3, and WHO to administer HPV vaccines to ten-year-old girls throughout the country.